Admin Log in
Empagliflozin and clinical outcomes in patients with type 2 diabetes, established cardiovascular disease and chronic kidney disease.
Lachin, John M
A - Z Index
GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the
Accessibility Feedback Form